Simon J Hall, MD
- A Registry of Sipuleucel-T Therapy in Men with Advanced Prostate Cancer
Individuals who are now receiving Sipuleucel-T (Provenge®) on a commercial basis will be asked to participate in a registry. This registry will collect demographic information disease status, medical history and prognostic factors. All side effects observed during or following...